Literature DB >> 23760324

Use of intralesional bleomycin as primary therapy in macrocystic lymphangiomas.

Vishesh Jain, Anup Mohta, Mamta Sengar, Kalpana Bansal, Kuldeep Valvi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23760324     DOI： 10.4103/0378-6323.113089

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  2 in total

1.  Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?

Authors:  Vijai Datta Upadhyaya; Ankur Bhatnagar; Basant Kumar; Zafar Neyaz; J S Kishore; Eti Sthapak
Journal:  Indian J Plast Surg       Date:  2018 Jan-Apr

2.  Results of Injection Sclerotherapy with Bleomycin in Pediatric Lymphatic Malformations.

Authors:  Vipan Kumar; Subhasis Roy Choudhury; Partap Singh Yadav; Vikram Khanna; Amit Gupta; Rajiv Chadha; Rama Anand
Journal:  J Indian Assoc Pediatr Surg       Date:  2021-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.